[Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study].

PubWeight™: 0.84‹?›

🔗 View Article (PMID 21376831)

Published in Rev Iberoam Micol on March 03, 2011

Authors

Javier Pemán1, Emilia Cantón, Juan José Camarena Miñana, Julia Alcoba Florez, Julia Echeverria, David Navarro Ortega, José Martínez Alarcón, Dionisia Fontanals, Bárbara Gomila Sard, Buenaventura Buendía Moreno, Luis Torroba, Josefina Ayats, Miguel Ángel Bratos Pérez, María Alvarez Fernández, Ferrán Sánchez Reus, Isabel Fernández Natal, Gloria Royo García, Guillermo Ezpeleta, Estrella Martín-Mazuelos, Isabel Iglesias, Antonio Rezusta, Inmaculada Ramírez de Ocariz, Amelia Gómez Nieto, el Grupo de Estudio FUNGEMYCA

Author Affiliations

1: Servicio de Microbiología, Hospital Universitario La Fe, Valencia, España. peman_jav@gva.es

Articles by these authors

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70

Early insulin therapy in very-low-birth-weight infants. N Engl J Med (2008) 3.51

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2005) 3.41

Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med (2014) 2.95

Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr (2010) 2.50

Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study. Clin Infect Dis (2007) 2.27

Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother (2012) 1.95

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother (2004) 1.88

Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol (2006) 1.81

Antifungal drug resistance mechanisms. Expert Rev Anti Infect Ther (2009) 1.68

Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality. Crit Care Med (2004) 1.58

[Prevalence and risk factors of methicillin-resistant Staphylococcus aureus colonization among residents living in long-term care facilities in southern Spain]. Enferm Infecc Microbiol Clin (2011) 1.44

Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J Antimicrob Chemother (2012) 1.37

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother (2004) 1.33

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother (2012) 1.31

In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagn Microbiol Infect Dis (2003) 1.25

Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother (2013) 1.19

Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med (2004) 1.15

Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study. Antimicrob Agents Chemother (2005) 1.13

Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method. J Clin Microbiol (2012) 1.12

Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother (2003) 1.11

Molecular epidemiology of Panton-Valentine leukocidin-positive Staphylococcus aureus in Spain: emergence of the USA300 clone in an autochthonous population. J Clin Microbiol (2010) 1.05

Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia (2002) 1.01

Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies. Clin Infect Dis (2013) 0.99

Comparison of results obtained by testing with three different agar media and by the NCCLS M27-A method for in vitro testing of fluconazole against Candida spp. J Clin Microbiol (2003) 0.99

Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J (2006) 0.99

Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest (2009) 0.98

Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med (2012) 0.98

Variation assessment of airborne Alternaria and Cladosporium spores at different bioclimatical conditions. Mycol Res (2005) 0.98

Enterococcal meningitis: a clinical study of 39 cases and review of the literature. Medicine (Baltimore) (2003) 0.98

Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother (2010) 0.97

First Spanish case of onychomycosis caused by Chaetomium globosum. Med Mycol (2007) 0.92

[Epidemiology of candidemia in Spain - Multicenter study] Rev Iberoam Micol (2002) 0.92

Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples. J Virol Methods (2011) 0.92

Identification of novel vga(A)-carrying plasmids and a Tn5406-like transposon in meticillin-resistant Staphylococcus aureus and Staphylococcus epidermidis of human and animal origin. Int J Antimicrob Agents (2012) 0.92

A positional scanning combinatorial library of peptoids as a source of biological active molecules: identification of antimicrobials. J Comb Chem (2003) 0.92

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital. Medicine (Baltimore) (2011) 0.91

The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis (2011) 0.91

Differentiation of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis by specific PCR amplification of the RPS0 intron. Int J Med Microbiol (2011) 0.90

B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain. J Clin Microbiol (2008) 0.90

In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev Iberoam Micol (2004) 0.90

Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts. J Antimicrob Chemother (2007) 0.89

Infections due to Phialemonium species: case report and review. Med Mycol (2009) 0.89

Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery. Diagn Microbiol Infect Dis (2010) 0.88

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period. Diagn Microbiol Infect Dis (2007) 0.88

Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag (2006) 0.86

Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens. Diagn Microbiol Infect Dis (2012) 0.86

Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes. PLoS One (2013) 0.86

Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P. Chemotherapy (2002) 0.86

Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol (2008) 0.86

New genetic environments of aac(6')-Ib-cr gene in a multiresistant Klebsiella oxytoca strain causing an outbreak in a pediatric intensive care unit. Diagn Microbiol Infect Dis (2011) 0.86

Effects of meteorological factors on the levels of Alternaria spores on a potato crop. Int J Biometeorol (2010) 0.86

High prevalence of spa types associated with the clonal lineage CC398 among tetracycline-resistant methicillin-resistant Staphylococcus aureus strains in a Spanish hospital. J Antimicrob Chemother (2011) 0.85

Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates. Diagn Microbiol Infect Dis (2011) 0.84

Detection of clonally related vanB2-containing Enterococcus faecium strains in two Spanish hospitals. J Med Microbiol (2006) 0.84

Fungal postoperative spondylodiscitis due to Scedosporium prolificans. Spine J (2009) 0.84

Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Med Mycol (2010) 0.84

[Photodynamic therapy for onychomycosis. case report and review of the literature]. Rev Iberoam Micol (2011) 0.83

Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp. J Clin Microbiol (2004) 0.82

Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol (2011) 0.82

Molecular detection and identification of Aspergillus spp. from clinical samples using real-time PCR. Mycoses (2008) 0.82

Inter-single-sequence-repeat-PCR typing as a new tool for identification of Microsporum canis strains. J Dermatol Sci (2005) 0.82

Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns. J Clin Microbiol (2006) 0.82

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients. BMC Infect Dis (2011) 0.82

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey. J Clin Microbiol (2011) 0.81

Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis (2011) 0.81

Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults. Scand J Infect Dis (2014) 0.81

Relapse of cutaneous alternaria infectoria in a renal transplant recipient after 2 years. Acta Derm Venereol (2006) 0.80

[Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain)]. Enferm Infecc Microbiol Clin (2011) 0.80

[Genotypes of Candida dubliniensis in clinical isolates]. Rev Iberoam Micol (2004) 0.80

[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review]. Rev Iberoam Micol (2007) 0.80

On the mechanism of Candida spp. photoinactivation by hypericin. Photochem Photobiol Sci (2012) 0.79

Potential fungicidal effect of voriconazole against Candida spp. Int J Antimicrob Agents (2005) 0.79

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? Ther Clin Risk Manag (2008) 0.79

[Activity of anidulafungin against Candida biofilms]. Rev Iberoam Micol (2008) 0.79

[Distal onycholysis resolved with photodynamic therapy in an elderly patient on multiple medication]. Enferm Infecc Microbiol Clin (2011) 0.79

Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain. Int J Antimicrob Agents (2007) 0.79

In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same? Enferm Infecc Microbiol Clin (2011) 0.79

Effect of statin use on outcomes of adults with candidemia. PLoS One (2013) 0.79

[Age group, geographical incidence and patterns of antifungal susceptibility of Candida species causing candidemia in the Spanish paediatric population]. Enferm Infecc Microbiol Clin (2013) 0.78

Two lymphogranuloma venereum cases in a heterosexual couple in Bilbao (Spain). Sex Transm Dis (2008) 0.78

[In vitro antifungal activity of micafungin]. Rev Iberoam Micol (2009) 0.78

Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis. Diagn Microbiol Infect Dis (2012) 0.78

Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes. Med Mycol (2008) 0.78

[Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine]. Med Clin (Barc) (2007) 0.78

[In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Rev Iberoam Micol (2007) 0.78

In vitro fungicidal photodynamic effect of hypericin on Trichophyton spp. Mycopathologia (2014) 0.78

Identification of international circulating lineages of meticillin-resistant Staphylococcus aureus in the north of Spain and their glycopeptide and linezolid susceptibility. J Med Microbiol (2011) 0.77

[Invasive fungal disease: conventional or molecular mycological diagnosis?]. Enferm Infecc Microbiol Clin (2011) 0.77

Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp. Diagn Microbiol Infect Dis (2012) 0.76

Multicenter study evaluating the role of enterococci in secondary bacterial peritonitis. J Clin Microbiol (2009) 0.76

Cutaneous sporotrichosis treated with photodynamic therapy: an in vitro and in vivo study. Photomed Laser Surg (2013) 0.76